David Link's most recent trade in Appian Corp - Ordinary Shares - Class A was a trade of 771 Class A Common Stock done . Disclosure was reported to the exchange on Feb. 4, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Appian Corp (Class A) | David Forrest Link | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2026 | 771 | 771 (0%) | 0% | 0 | Class A Common Stock | |
| SAB Biotherapeutics Inc | David Link | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2025 | 150,000 | 150,000 | - | - | Stock Option (right to buy) | |
| SAB Biotherapeutics Inc | David Link | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2024 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| SAB Biotherapeutics Inc | David Link | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2024 | 9,305 | 9,305 | - | - | Stock Option (right to buy) | |
| SAB Biotherapeutics Inc | David Link | Director | Grant, award, or other acquisition of securities at price $ 1.20 per share. | 07 Dec 2022 | 41,493 | 57,313 | - | 1.2 | 49,999 | Common Stock |
| SAB Biotherapeutics Inc | David Link | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Dec 2022 | 41,493 | 41,493 | - | - | Warrant (Common Stock) | |
| SAB Biotherapeutics Inc | David Link | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Oct 2021 | 69,793 | 69,793 | - | - | Employee Stock Option (right to buy) | |
| SAB Biotherapeutics Inc | David Link | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Oct 2021 | 23,264 | 23,264 | - | - | Employee Stock Option (right to buy) | |
| SAB Biotherapeutics Inc | David Link | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Oct 2021 | 17,231 | 17,231 | - | - | Earnout Rights (Restricted Stock Units) | |
| SAB Biotherapeutics Inc | David Link | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Oct 2021 | 15,820 | 15,820 | - | - | Common Stock | |
| SAB Biotherapeutics Inc | David Link | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Oct 2021 | 12,097 | 12,097 | - | - | Common Stock | |
| SAB Biotherapeutics Inc | David Link | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Oct 2021 | 6,391 | 6,391 | - | - | Earnout Rights (Common Stock) | |
| SAB Biotherapeutics Inc | David Link | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Oct 2021 | 4,887 | 4,887 | - | - | Earnout Rights (Common Stock) |